Apimeds Pharmaceuticals (APUS) IPO deck
Apimeds Pharmaceuticals is a clinical-stage biopharmaceutical company developing Apitox, a bee venom-based therapy for inflammation and pain management in knee osteoarthritis and multiple sclerosis.
Apimeds Pharmaceuticals is a clinical-stage biopharmaceutical company developing Apitox, a bee venom-based therapy for inflammation and pain management in knee osteoarthritis and multiple sclerosis.
%20IPO%20deck){kind=link}